Showing results (781-790 of 895) with videos related to

Sort By:
Pageof 90
Nature Chemical Biology|March 25, 2022
Systematic identification of biomarker-driven drug combinations to overcome resistanceMatthew G Rees, Lisa Brenan, Mariana do Carmo, et al.
British Journal of Pharmacology|August 24, 2012
Protein engineering and preclinical development of a GM-CSF receptor antibody for the treatment of rheumatoid arthritisR R Minter, E S Cohen, B Wang, et al.
Nature Chemical Biology|October 26, 2023
Targeting ROS production through inhibition of NADPH oxidasesJoana Reis, Christoph Gorgulla, Marta Massari, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Application of a new highly multiplexed amplicon sequencing tool to evaluate Plasmodium falciparum antimalarial resistance and relatedness in individual and pooled samples from Dschang, CameroonJacob M Sadler, Alfred Simkin, Valery P K Tchuenkam, et al.
PLOS Digital Health|July 25, 2023
Real-world evidence from the first online healthcare analytics platform-Livingstone. Validation of its descriptive epidemiology moduleBenjamin R Heywood, Christopher Ll Morgan, Thomas R Berni, et al.
Nature|February 26, 2025
Humans in Africa's wet tropical forests 150 thousand years agoEslem Ben Arous, James A Blinkhorn, Sarah Elliott, et al.
Frontiers in Parasitology|February 20, 2025
Application of a new highly multiplexed amplicon sequencing tool to evaluate Plasmodium falciparum antimalarial resistance and relatedness in individual and pooled samples from Dschang, CameroonJacob M Sadler, Alfred Simkin, Valery P K Tchuenkam, et al.
Cancer Research|March 15, 2024
A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH MedulloblastomaGrace H Hwang, Maria F Pazyra-Murphy, Hyuk-Soo Seo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2012
Human papillomavirus modifies the prognostic significance of T stage and possibly N stage in tonsillar cancerA M Hong, A Martin, B K Armstrong, et al.
Journal of the American Chemical Society|May 30, 2024
Mechanism of Action of KL-50, a Candidate Imidazotetrazine for the Treatment of Drug-Resistant Brain CancersEric D Huseman, Anna Lo, Olga Fedorova, et al.
Pageof 90